International Immunopharmacology

雜志介紹

International Immunopharmacology雜志介紹

《International Immunopharmacology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱國際免疫藥理學，本刊主要出版、報道醫學-IMMUNOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為4.8，最新CiteScore 指數為8.4。

本刊近期中國學者發表的論文主要有：

• Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels

  Author: Jin, Xiaoxing; Wang, Xiaofei; Sun, Ji; Tan, Wuping; Zhang, Guocheng; Han, Jiapeng; Xie, Mengjie; Zhou, Liping; Yu, Zhiyao; Xu, Tianyou; Wang, Changyi; Wang, Yueyi; Zhou, Xiaoya; Jiang, Hong

• PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38

  Author: Luo, Yanwen; Zhu, Jiefu; Zhao, Fan; Shi, Lang; Li, Yuzhen; Wu, Xiongfei

• Association between serum levels of 12 different cytokines and short-term efficacy of anti-PD-1 monoclonal antibody combined with chemotherapy in advanced gastric cancer

  Author: Qi, Qiufeng; Peng, Yun; Zhu, Ming; Zhang, Yaping; Bao, Yanqing; Zhang, Xiaobin; Zhang, Jianqing; Liu, Yongping

• Intralesional Bacillus Calmette-Gu?erin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses

  Author: Yang, Hanshan; Hu, Yuru; Kong, Deyi; Chen, Ping; Yang, Linglin

英文介紹

International Immunopharmacology雜志英文介紹

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.

The subject material appropriate for submission includes:

? Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.

? Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.

? Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.

? Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.

? Agents that activate genes or modify transcription and translation within the immune response.

? Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.

? Production, function and regulation of cytokines and their receptors.

? Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.